Intermountain Health logo

Welcome to AHA Scientific Sessions

We’re excited to join with fellow researchers, cardiologists, and practitioners at the 2025 American Heart Association’s Scientific Sessions in New Orleans. We look forward to discussing the latest research and best practices in heart care and invite you to join us at our booth to identify ways we can collaborate. We also have a free pair of socks for you, just for stopping by to say hello.

Visit us at Booth #3137!

Join our Email List

Intermountain Health booth
Blake Gardner, Senior Medical Director

Our Vision

Become a model Heart & Vascular Program on a regional, national, and international level by providing high-quality and cost-effective CV care to patients in our communities with a differentiated experience.

Learn more about our Heart & Vascular Program with the 2024 annual report

Group of Intermountain Health employees

Now Hiring!

We have several positions available in our Heart & Vascular Program at Intermountain Health. Here are two roles we’re actively seeking to fill, but we encourage you to explore all the options available in Utah, Idaho, Nevada, Colorado, and Montana.

Our Research at Scientific Sessions

Our investigators will be presenting 12 research findings during the four-day conference. Follow the latest news information on several research studies and their impact on the understanding and treatment of heart disease.

Familial Clustering of Mital Valve Prolapse and Mitral Valve Regurgitation

Primary Author: Stacey Knight, PhD

Saturday, November 8th (10:30 - 11:30 pm)

Basic Science Zone, Poster Board #4031

Prevalence of Non-Coronary Incidental Findings Identified on CT Coronary Artery Calcium Scans Performed on Patients Enrolled in the CorCal Study. Do we need to keep track of them?

Primary Author: Joseph "Brent" Muhlestein, MD

Saturday, November 8th (11:27 am)

Clinical Science Zone 1, Moderated 8

Coronary Artery Calcium Predicts All-cause and Non-coronary Mortality

Primary Author: Jeffrey L. Anderson, MD

Saturday, November 8th (11:34 am)

Population Science Zone, Moderated 12

A Randomized Clinical Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Acute Coronary Syndrome Patients: The TARGET-D Trial

Primary Author: Heidi May, PhD, MSPH

Sunday, November 9th (9:15 am)

Clinical Science Zone 1, Moderated 5

Long-Term Cardiovascular Risks Based on Stratification by Severity of Hypertension Disorders of Pregnancy

Primary Author: Kismet Rasmusson, FNP-BC, FAHA, CHFN

Sunday, November 9th (9:22 am)

Population Science Zone, Moderated 12

The Risk of Pancreatitis and Adverse Cardiovascular Events in Patients with Type 2 Diabetes and/or Overweight/Obesity with and without Hypertriglyceridemia when Prescribed GLP1RA: A Propensity Score-Matched Analysis

Primary Author: Leslie Iverson, PA

Sunday, November 9th (12:32 pm)

Population Science Zone, Moderated 10

Distribution and clinical impact of polygenetic risk scores in younger subjects at uncertain coronary risk 

Primary Author: Leslie Iverson, PA

Sunday, November 9th (3:15 - 4:15 pm)

Basic Science Zone, Poster #4037

Stroke Volume Work Index from speckle tracking is associated with mortality in critically ill patients with sepsis and septic shock

Primary Author: Michael Lanspa, MD

Sunday, November 9th (3:36 pm)

Clinical Science Zone 1, Moderated 7

Lipoprotein (a) [Lp(a)] levels are not associated with MACE outcomes in patients with suspected CAD referred for Cardiac PET/CT stress tests in an integrated health system

Primary Author: Viet Le, PA-C

Monday, November 10th (10:30 - 11:30 am)

Population Science Zone, Poster #2013

Baseline Severity of Coronary Artery Calcium Among Patients Enrolled in the CorCal Trial Compared to those Enrolled in the MESA Study

Primary Author: Joseph "Brent" Muhlestein, MD

Monday, November 10th (12:50 pm)

Clinical Science Zone 1, Moderated 6

Prevalence of atrial fibrillation increases major adverse cardiovascular events, particularly heart failure hospitalization, in patients with peripheral arterial disease

Primary Author: Viet Le, PA-C

Monday, November 10th (12:50 pm)

Population Science Zone, Moderated 10

Selecting Statins in Primary Prevention: A Comparison by the Pooled Cohort Equation or by the Coronary Artery Calcium Score in Women and Men: The CorCal Outcomes Randomized Clinical Trial

Primary Author: Jeffrey L. Anderson, MD

Monday, November 10th (2:06 pm)

Population Science Zone, Moderated 12

CME Learning Opportunities

  • Cardiovascular Update | March 7, 2026 in Park City, Utah | In-person and virtual attendance available
  • Core Curriculum Review: Cardiothoracic Surgery Board Exam Preparation Course | Sept. 12-14, 2026 in Salt Lake City, Utah

Email tessa.vaschel@imail.org for more information.

Doctor presenting at a conference

Join Our Email List

Join our email list to receive a quarterly email about the latest news, research, and career opportunities from Intermountain Health.

Join Today!

Sign up graphic

About Intermountain Health

Based in Salt Lake City, UT, Intermountain serves patients and communities in Utah, Idaho, Nevada, Colorado, Montana, and Wyoming, with 34 hospitals and 400 clinics across the region. 

Learn more

Sign In
Create Account

Copyright 2026, Intermountain Health, All rights reserved.